BNP Paribas Financial Markets’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$252K Sell
26,771
-314,900
-92% -$2.82M ﹤0.01% 4126
2026
Q1
$2.78M Sell
341,671
-171,258
-33% -$1.55M ﹤0.01% 2460
2025
Q4
$3.45M Buy
512,929
+474,833
+1,246% +$3.58M ﹤0.01% 2280
2025
Q3
$330K Buy
38,096
+14,923
+64% +$116K ﹤0.01% 3772
2025
Q2
$146K Sell
23,173
-954,294
-98% -$6.32M ﹤0.01% 3894
2025
Q1
$6.27M Buy
977,467
+420,635
+76% +$3.48M ﹤0.01% 1675
2024
Q4
$4.48M Buy
556,832
+413,676
+289% +$3.99M ﹤0.01% 1855
2024
Q3
$1.81M Sell
143,156
-210,795
-60% -$2.72M ﹤0.01% 2106
2024
Q2
$4.48M Sell
353,951
-141,428
-29% -$1.42M ﹤0.01% 1472
2024
Q1
$2.37M Sell
495,379
-366,100
-42% -$1.7M ﹤0.01% 1959
2023
Q4
$4.14M Buy
861,479
+278,381
+48% +$1.7M ﹤0.01% 1532
2023
Q3
$4.22M Buy
583,098
+157,938
+37% +$1.26M 0.01% 1385
2023
Q2
$3.16M Sell
425,160
-260,560
-38% -$2.05M ﹤0.01% 1485
2023
Q1
$4.75M Buy
685,720
+83,857
+14% +$772K 0.01% 1274
2022
Q4
$6.19M Buy
601,863
+237,356
+65% +$4.19M 0.01% 1206
2022
Q3
$6.63M Buy
364,507
+251,802
+223% +$10.9M 0.01% 1220
2022
Q2
$5.8M Sell
112,705
-17,917
-14% -$928K 0.01% 1165
2022
Q1
$9.62M Buy
130,622
+44,901
+52% +$4M 0.01% 950
2021
Q4
$12.3M Buy
85,721
+61,925
+260% +$10.6M 0.02% 865
2021
Q3
$4.93M Buy
23,796
+4,944
+26% +$1.09M 0.01% 1315
2021
Q2
$4M Sell
18,852
-12,456
-40% -$2.28M 0.01% 1413
2021
Q1
$5.68M Sell
31,308
-29,585
-49% -$5.9M 0.01% 1093
2020
Q4
$6.79M Buy
60,893
+45,097
+285% +$4.79M 0.01% 970
2020
Q3
$1.71M Buy
15,796
+10,217
+183% +$1.24M ﹤0.01% 1581
2020
Q2
$465K Sell
5,579
-4,261
-43% -$163K ﹤0.01% 2131
2020
Q1
$134K Buy
9,840
+4,243
+76% +$35.9K ﹤0.01% 3067
2019
Q4
$22.3K Buy
5,597
+2,325
+71% +$10.1K ﹤0.01% 3967
2019
Q3
$16.4K Buy
3,272
+1,161
+55% +$6.35K ﹤0.01% 4036
2019
Q2
$12.4K Sell
2,111
-1,856
-47% -$14.6K ﹤0.01% 4057
2019
Q1
$43.7K Buy
3,967
+3,916
+7,678% +$124K ﹤0.01% 3581
2018
Q4
$1.88K Sell
51
-584
-92% -$22.6K ﹤0.01% 3812
2018
Q3
$23.9K Sell
635
-196
-24% -$5.52K ﹤0.01% 3341
2018
Q2
$22.3K Sell
831
-2,459
-75% -$83.1K ﹤0.01% 3455
2018
Q1
$138K Sell
3,290
-358
-10% -$14.4K ﹤0.01% 3023
2017
Q4
$90.5K Buy
3,648
+2,171
+147% +$53K ﹤0.01% 3355
2017
Q3
$33.7K Sell
1,477
-170
-10% -$3.81K ﹤0.01% 3351
2017
Q2
$37.9K Buy
1,647
+1,327
+415% +$26K ﹤0.01% 3336
2017
Q1
$8.18K Sell
320
-136
-30% -$3.74K ﹤0.01% 3208
2016
Q4
$11.5K Sell
456
-4,448
-91% -$130K ﹤0.01% 3390
2016
Q3
$204K Sell
4,904
-860
-15% -$111K ﹤0.01% 1737
2016
Q2
$838K Buy
5,764
+1,274
+28% +$146K ﹤0.01% 1261
2016
Q1
$463K Sell
4,490
-1,086
-19% -$116K ﹤0.01% 1221
2015
Q4
$936K Sell
5,576
-566
-9% -$87.1K ﹤0.01% 933
2015
Q3
$868K Buy
6,142
+286
+5% +$64.1K ﹤0.01% 1091
2015
Q2
$1.3M Buy
5,856
+5,455
+1,360% +$959K ﹤0.01% 1043
2015
Q1
$66.2K Buy
+401
New +$65.1K ﹤0.01% 1841
2014
Q4
Sell
-706
Closed -$58.9K 2808
2014
Q3
$58.9K Buy
706
+700
+11,667% +$63.3K ﹤0.01% 2496
2014
Q2
$578 Sell
6
-2
-25% -$176 ﹤0.01% 3563
2014
Q1
$705 Sell
8
-113
-93% -$12.6K ﹤0.01% 2965
2013
Q4
$12.4K Sell
121
-1,754
-94% -$124K ﹤0.01% 2513
2013
Q3
$118K Sell
1,875
-450
-19% -$25.3K ﹤0.01% 2390
2013
Q2
$95.3K Buy
+2,325
New +$101K ﹤0.01% 2540

Other funds holding NVAX

BNP Paribas Financial Markets's NVAX Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its Novavax (NVAX) stake by 92% in Q2 2026, selling an estimated $2.82M and leaving 26,771 shares worth $252K. The position accounts for ﹤0.01% of the portfolio, ranked #4126.

BNP Paribas Financial Markets first reported a position in NVAX in Q2 2013 and has held it in 52 quarters since. The position peaked at $12.3M in Q4 2021. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • BNP Paribas Financial Markets held 26,771 shares of Novavax worth $252K as of Q2 2026.
  • BNP Paribas Financial Markets sold 314,900 Novavax shares in Q2 2026, an estimated $2.82M.
  • Novavax made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #4126 holding.
  • BNP Paribas Financial Markets first reported a position in Novavax in Q2 2013 and has held it in 52 quarters since.
  • BNP Paribas Financial Markets's Novavax position peaked at $12.3M in Q4 2021.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.